FDA must regulate stem cell therapies to mitigate risks to patients and the public. Pike T, Chirba MA, Aaron DG. Proc Natl Acad Sci U S A 2026;123:e2508586123.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pike T, Chirba MA, Aaron DG. FDA must regulate stem cell therapies to mitigate risks to patients and the public. Proc Natl Acad Sci U S A 2026;123:e2508586123.
PMID: 41811453